MedSurg and Neurotechnology — Net Sales
Stryker MedSurg and Neurotechnology — Net Sales increased by 0.8% to $3.80B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.0%, from $3.22B to $3.80B. Over 3 years (FY 2021 to FY 2024), MedSurg and Neurotechnology — Net Sales shows an upward trend with a 12.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for the segment's medical devices, while a decrease suggests potential market saturation or competitive pressure.
Detailed definition
Represents the total revenue generated from the sale of medical surgical equipment, neurotechnology devices, and related...
Peer comparison
Comparable to segment-level revenue reporting in other diversified medical device manufacturers.
syk_segment_medsurg_and_neurotechnology_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.36B | $2.35B | $2.64B | $2.42B | $2.55B | $2.59B | $3.05B | $2.69B | $2.86B | $2.86B | $3.43B | $3.00B | $3.12B | $3.22B | $4.18B | $3.51B | $3.77B | $3.80B |
| QoQ Change | — | -0.4% | +12.3% | -8.2% | +5.2% | +1.5% | +17.9% | -11.8% | +6.3% | -0.0% | +19.9% | -12.5% | +3.9% | +3.4% | +29.6% | -16.0% | +7.4% | +0.8% |
| YoY Change | — | — | — | — | +8.1% | +10.2% | +15.6% | +11.0% | +12.2% | +10.5% | +12.3% | +11.5% | +9.0% | +12.8% | +21.9% | +17.1% | +21.0% | +18.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's medsurg and neurotechnology — net sales?
- Stryker (SYK) reported medsurg and neurotechnology — net sales of $3.80B in Q3 2025.
- How has Stryker's medsurg and neurotechnology — net sales changed year-over-year?
- Stryker's medsurg and neurotechnology — net sales increased by 18.0% year-over-year, from $3.22B to $3.80B.
- What is the long-term trend for Stryker's medsurg and neurotechnology — net sales?
- Over 3 years (2021 to 2024), Stryker's medsurg and neurotechnology — net sales has grown at a 12.3% compound annual growth rate (CAGR), from $9.54B to $13.52B.
- What does medsurg and neurotechnology — net sales mean?
- The total revenue earned from the MedSurg and Neurotechnology business segment.